Chiron Real Estate Inc. (XRN US)
XRN US$28.77
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.
Share price activity
Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
- Last (Price)
- 28.77
- Change
- ▼ -0.19 (-0.66)
- Bid / Ask
- 28.73 - 28.77
- Volume
- 85,390
- Turnover
- 2,002,417
- Open
- 28.74
- Day Range
- 28.15 - 28.81
- VWAP
- 28.63
- Prev Close
- 28.96
- Last Trade
- 28/10 4:10pm
Key information
Displays key information on the security, sourced from Morningstar.
- Sector
- Real Estate
- Shares Issued
- 13,237,830
- NTA/Share
- 36.11
- Last Dividend
- 0.16
- Dividend Ex Date
- 20 OCT 2026
- Dividend Pay Date
- 13 NOV 2026
Current (USD) · FY2025
Displays key financial data for the most recent fiscal year, in millions. Note - Per share data is in local currency terms irrespective of reporting currency, and may be different to the stated currency, sourced from Morningstar.
- Revenue
- 147.68
- EBITDA
- 83.56
- Profit
- -12.12
- Earnings Per Share (EPS)
- -0.91
- Dividend Per Share (DPS)
- 6.30
- Yield %
- 7.67
- Market Cap
- 380.85
- Price to Earnings Ratio (P/E)
- 7.73
Estimates (USD) · FY2027
Displays consensus analyst’s estimates for key measures for the next fiscal year, sourced from Morningstar.
- Revenue
- 183.38
- EBITDA
- —
- Profit
- -22.89
- Earnings Per Share (EPS)
- 0.05
- Dividend Per Share (DPS)
- 1.92
Quantitative rating
Displays Morningstar’s Quantitative Equity Research Rating for the security: a star rating from 1 (overvalued) to 5 (undervalued) from the share price against a fair value estimated by a statistical model of Morningstar’s analyst ratings, with the model’s economic moat, financial health and fair value uncertainty, sourced from Morningstar.
Undervalued
- Economic Moat
- None
- Financial Health
- Moderate
- Uncertainty
- Medium
Morningstar Quantitative Rating as of 23 OCT 2026.
Quantitative Equity Rating Methodology – view here
Fair value estimate
Displays Morningstar’s quantitative fair value estimate for the security against the current share price, with the band around it: the five-star price below which the model would rate the stock five stars and the one-star price above which it would rate it one star, sourced from Morningstar.
Five-star price 33.54 Fair value 39.99 One-star price 47.67
Morningstar Quantitative Rating as of 23 OCT 2026.
Quantitative valuation
Displays where the share price sits in Morningstar’s quantitative fair value band, from the five-star price (undervalued) to the one-star price (overvalued), with the fair value estimate, the price to fair value ratio, the model’s valuation label and its uncertainty rating, sourced from Morningstar.
Buy
Sell
- Fair Value
- 39.99
- Price / Fair Value
- 0.75
- Valuation
- Undervalued
- Uncertainty
- Medium
Morningstar Quantitative Rating as of 23 OCT 2026. The slider runs from the five-star price (33.54) to the one-star price (47.67).
Displays useful ratios for the security, NB the pricing date used, sourced from Morningstar.
| Ratios |
|---|
| Currency (Price/reporting): USD/USD |
| Exchange Rate: 1.0000 |
Price, volume and trading statistics for the security, sourced from Morningstar.
| Price - closing or last bid | 30.00 |
| Price - 12 month high | 38.65 |
| Price - 12 month low | 28.67 |
| Pricing date | 22 OCT 2026 |
| Volume - avg. trading volume for the last ten days | 0.21 |
| Market capitalization | 397.13 |
| 12 Month High price date | 2 JUL 2026 |
| 12 Month Low price date | 21 OCT 2026 |
| Volume - avg. trading volume for the last 3 months | 0.12 |
| Price - 1 Day % Change | -0.53% |
| Price - 13 week price percent change | -19.72% |
| Price - 26 week price percent change | -14.60% |
| Price - 5 Day % Change | -1.12% |
| Price - 52 week price percent change | — |
| Price - YTD price percent change | -11.43% |
| Price % Change Month To Date | -15.66% |
Earnings, dividends, cash flow and book value per share, sourced from Morningstar.
| EPS excluding extraordinary items - most recent fiscal year | -0.910 |
| EPS excluding extraordinary items - trailing 12 month | 3.720 |
| EPS Normalized - most recent fiscal year | 0.399 |
| Revenue/share - most recent fiscal year | 11.038 |
| Revenue/share - trailing 12 month | 11.431 |
| Book value per share - most recent fiscal year | 29.140 |
| Book value per share - most recent quarter | 32.998 |
| Book value (tangible) per share - most recent fiscal year | 36.105 |
| Book value (tangible) per share - most recent quarter | 47.636 |
| Cash per share - most recent fiscal year | 0.686 |
| Cash per share - most recent quarter | 0.805 |
| Cash Flow per share - most recent fiscal year | 5.326 |
| Cash Flow per share - trailing 12 month | 5.434 |
| Dividend per share - most recent fiscal year | — |
| Dividends per share - trailing 12 month | 2.300 |
| EBITD per share - trailing 12 month | 11.626 |
| EPS Basic excluding extraordinary items - most recent fiscal year | -0.910 |
| EPS Basic excluding extraordinary items - trailing 12 month | 3.720 |
| EPS including extraordinary items - most recent fiscal year | -0.910 |
| EPS including extraordinary items - trailing 12 month | 3.730 |
| Free Cash Flow per share - trailing 12 month | -14.308 |
Valuation multiples such as P/E, price to sales, price to book and enterprise value ratios, sourced from Morningstar.
| P/E excluding extraordinary items, most recent fiscal year | 8.06 |
| P/E Normalized, most recent fiscal year | 6.25 |
| Price to sales - most recent fiscal year | 2.62 |
| Price to Tangible Book - most fiscal year | 1.04 |
| Price to Free Cash Flow per Share - most recent fiscal year | — |
| Price to Cash Flow per share - trailing 12 month | 5.52 |
| Price to Book - most recent fiscal year | 0.91 |
| P/E excluding extraordinary items high, trailing 12 months | 91.86 |
| P/E excluding extraordinary items low, trailing 12 months | 7.75 |
| Net Debt, LFI | 635.85 |
| Net Debt, LFY | 658.21 |
| Dividend Yield - 5 Year Average | 9.08% |
| Dividend Yield - indicated annual dividend divided by closing price | 7.63% |
| Current Dividend Yield - Common Stock Primary Issue, LTM | 7.67% |
Cash flow, liquidity and leverage measures, sourced from Morningstar.
| Free Cash Flow - most recent fiscal year | -10.43 |
| LT debt/equity - most recent fiscal year | 2.75% |
| Payout ratio - most recent fiscal year | — |
| Total debt/total equity - most recent fiscal year | 125.89% |
| LT debt/equity - most recent quarter | 94.51% |
| Total debt/total equity - most recent quarter | 94.51% |
| Free Cash Flow - trailing 12 month | -190.43 |
| Payout ratio - trailing 12 month | 60.32% |
Key income statement lines for the most recent fiscal year, in millions, sourced from Morningstar.
| Revenue - most recent fiscal year | 147.68 |
| Revenue - trailing 12 month | 152.13 |
| EBITD - most recent fiscal year | 83.56 |
| EBITD - trailing 12 month | 154.73 |
| Earnings before taxes - most recent fiscal year | -6.88 |
| Earnings before taxes - trailing 12 month | 62.73 |
| Net Income available to common - most recent fiscal year | -12.12 |
| Net Income available to common - trailing 12 months | 49.12 |
| Earnings before taxes Normalized - most recent fiscal year | 10.63 |
| Net Income Available to Common, Normalized - most recent fiscal year | — |
| Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM | 4.80 |
Profitability margins for the most recent fiscal year, sourced from Morningstar.
| Net Profit Margin % - 1st historical fiscal year | -4.66% |
| Net Profit Margin % - trailing 12 month | 41.23% |
| Operating margin - 1st historical fiscal year | 24.39% |
| Operating margin - trailing 12 month | 23.23% |
| Pretax margin - trailing 12 month | 41.23% |
| Pretax margin - 1st historical fiscal year | -4.66% |
| Operating Margin - 5 year average | 27.01% |
| Pretax Margin - 5 year average | 9.20% |
| Free Operating Cash Flow/Revenue, 5 Year Average | -30.93% |
| Free Operating Cash Flow/Revenue, TTM | -125.17% |
| Net Profit Margin - 5 year average | 9.20% |
Returns on average assets and equity for the fiscal year, the trailing 12 months and as 5 year averages, and net income and revenue per employee in whole currency, sourced from Morningstar.
| Return on average assets - most recent fiscal year | -0.54% |
| Return on average assets - trailing 12 month | 4.88% |
| Return on average equity - most recent fiscal year | -1.62% |
| Return on average equity - trailing 12 month | 15.40% |
| Return on average assets - 5 year average | 1.21% |
| Return on average equity - 5 year average | 3.10% |
| Net Income/employee - most recent fiscal year | -229,433.33 |
| Revenue/employee - most recent fiscal year | 4,922,733.33 |
Growth in revenue, earnings, dividends and book value over recent periods, sourced from Morningstar.
| Revenue growth rate, 5 year | 9.57% |
| EPS growth rate, 5 year | — |
| Growth rate% - dividend, 3 year | 14.47% |
| Revenue/share (5 yr growth) | 1.78% |
| Growth rate% - Revenue, 3 year | 2.49% |
| Growth rate% - EPS, 3 year | — |
| Book value per share growth rate, 5 year | -4.86% |
| Capital Spending growth rate, 5 year | -17.88% |
| Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR | 9.53% |
Displays analyst’s forecasts for key measures. The estimates can be expanded to see the spread of the calls. Full lines = reported, and dotted lines are forward estimates. Click a measure to add or remove it from the chart, sourced from Morningstar.
Financial forecast (USD, millions except per share)
| Actuals | Estimates | |||||||
| 2025 | 2026 | 2027 | 2028 | 2029 | ||||
| Estimate breakdown | ||||||||
Financial metrics can be plotted on the graph to see trends. Multiple metrics from multiple statements can be plotted against each other, sourced from Morningstar.
Financials (USD, millions)
| Period end: | DEC 21 | DEC 22 | DEC 23 | DEC 24 | DEC 25 |
| Fiscal year: | 2021 | 2022 | 2023 | 2024 | 2025 |
| Period length: | 12 months | 12 months | 12 months | 12 months | 12 months |
Displays all company announcements released by the company to the exchange, sourced from Morningstar.
Announcements
Announcements are available for ASX-listed companies only.
Opinion
No opinions for this company yet.
Action
No actions for this company yet.
Business Summary
Chiron Real Estate Inc is a real estate investment trust focused on investing and actively managing critical healthcare infrastructure. Its portfolio includes Spectrum-Dumfries, Slippery Rock MOB, Gainesville Eye Center, Aurora Sports Health, and many Others. Geographically, the company has it's concentration in a small number of states, including Texas, Florida, Ohio, Arizona, Pennsylvania, and Illinois.
Relevant suggested news and content from the site
Video
WATCH
Webinar Recording: Are commodities entering a Supercycle?
Recorded Wednesday 24th June @ 12.30pm
Podcast
LISTEN
Thursday 11th September – Dow off -220pts, SPI off -20pts
Daily Podcast Direct from the Desk
Video
WATCH
Buy Hold Sell: The 6 income stocks readers love, plus 2 expert ideas
Recorded 10th June 2026
Podcast
LISTEN
Wednesday 10th September – Dow up +196pts, SPI down -4pts
Daily Podcast Direct from the Desk
